Skip to main content

Table 2 Characteristics of experimental groups

From: Isolated downregulation of HCN2 in ventricles of rats with streptozotocin-induced diabetic cardiomyopathy

 

CON

STZ

Weight outcomes (n)

10

10

Body weight (g)

438 ± 15

289 ± 14*

Heart weight (mg)

1238 ± 83

840 ± 28*

Heart weight/body weight (mg/g)

2.8 ± 0.2

2.9 ± 0.1

Blood glucose measurement (n)

10

10

Casual glycaemia (mmol/l)

7.4 ± 0.5

20.4 ± 1.79*

Cardiac mRNA expression (n)

9

10

Myh6 (%, relative to controls)

100 ± 5

29 ± 4*

Myh7 (%, relative to controls)

100 ± 17

270 ± 16*

  1. Mean ± SEM, *p < 0.05 versus CON
  2. CON—controls, STZ—streptozotocin administered diabetic rats